tiprankstipranks
Trending News
More News >

Clover Biopharmaceuticals Announces Board and Committee Changes

Story Highlights
Clover Biopharmaceuticals Announces Board and Committee Changes

Don’t Miss TipRanks’ Half-Year Sale

An update from Clover Biopharmaceuticals Ltd. ( (HK:2197) ) is now available.

Clover Biopharmaceuticals Ltd. announced changes to its board of directors and committee memberships, effective July 1, 2025. Dr. Donna Marie Ambrosino and Mr. Xiang Liao have been appointed as members of the Nomination Committee, reflecting the company’s ongoing efforts to strengthen its governance structure.

More about Clover Biopharmaceuticals Ltd.

Clover Biopharmaceuticals Ltd. is a company incorporated in the Cayman Islands, focusing on the biopharmaceutical industry. It is involved in the development and commercialization of innovative vaccines and biologic therapeutic products.

Average Trading Volume: 1,252,715

Technical Sentiment Signal: Hold

Current Market Cap: HK$376.1M

Find detailed analytics on 2197 stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1